New DNA test could end years of uncertainty for mitochondrial disease patients
NCT ID NCT07511608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study aims to develop a new digital PCR technique to more accurately diagnose mitochondrial diseases. Researchers will test the method on blood, urine, saliva, and muscle fiber samples from 4 patients. If validated, the technique could be faster and cheaper than current methods, helping to provide definitive diagnoses for patients who currently have unclear genetic test results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital PCR test
What this could lead to
If successful, this could provide a faster, cheaper way to diagnose mitochondrial diseases, reducing the long diagnostic journey for many patients.
What could go wrong
This is a very small pilot study with only 4 participants. The technique may not prove reliable enough for routine clinical use, and further validation in larger studies is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITOCHONDRIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice - Service de Génétique Médicale
Nice, Provence-Alpes-Côte d'Azur Region, 06202, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupement Hospitalier Est Hospices civils de Lyon - Service de génétique médicale
Bron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Gui de Chauliac - Service de Neurologie
Montpellier, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••